StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
TBOTEK.NS$1229.60+0.02%
Fair $1229.60+0.0%

TBOTEK.NS

TBOTEK.NS

Consumer Cyclical / Travel ServicesNSE

$1229.60

+0.30 (+0.02%)

Fairly Valued+0.0%Fair Value $1229.60Fund rank 32/100 · Data gapFallback financials|
SA 39/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.9B · quality 58.7/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 49/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

39/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · TBOTEK.NSLocal privado en este navegador · TBOTEK.NS
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$131.3B

P/E

54.1x

↑

EV/EBITDA

30.6x

↑

ROE

15.8%

↑

Gross Margin

62.5%

↑

Debt/Equity

0.49

↑
52-Week Range$1230
$1004$1765

TradingView lightweight chart

TBOTEK.NS price, volumen y niveles de valoración

Último $1,230Periodo -12.6%
Fair value: $1,230

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+39.7%

FCF CAGR

—

FCF margin

-3.3%

FCF / Net income

-0.36x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $26.77B · net income $2.44B · FCF $-875.4M

2023-FY → 2026-FY

Gross margin

62.5%-3.7% pts

Operating margin

10.9%-8.6% pts

Net margin

9.1%-5.6% pts

FCF margin

-3.3%-26.7% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$26.77B$26.77B$17.37B$12.81B$9.83B
Net Income$2.44B$2.44B$2.30B$2.02B$1.44B
EBITDA$4.23B$4.23B$3.50B$2.74B$2.06B
EPS22.7622.7621.4818.6213.28
Gross Margin62.5%62.5%68.7%63.3%66.2%
Operating Margin10.9%10.9%14.5%20.0%19.5%
Net Margin9.1%9.1%13.2%15.8%14.7%
Balance Sheet
Debt/Equity0.490.490.180.390.21
Cash Flow
Free Cash Flow$-875.4M$-875.4M$2.36B$1.88B$2.30B
Returns
ROE15.8%15.8%19.2%37.1%42.4%
Valuation
P/E54.0754.0751.92——
EV/EBITDA30.5530.5531.99——
P/B8.518.519.99——
Growth & Yield
Revenue Growth54.1%54.1%35.6%30.3%—
EPS Growth6.0%6.0%15.4%40.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

68.6%

muy exigente

EPS terminal req.

$109.11

Spread vs growth

-62.7%

5Y implied EPS CAGR

42.1%

muy exigente

EPS terminal req.

$132.02

Spread vs growth

-36.2%

10Y implied EPS CAGR

25.0%

muy exigente

EPS terminal req.

$212.62

Spread vs growth

-19.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -5.7%

Total return

-5.7%

Start / end P/E

60.7x → 54.0x

EPS bridge

21.48 → 22.76

Residual

-0.7%

EPS growth+6.0%
Multiple rerating-11.0%
Dividend+0.0%
Residual / FX / buybacks / cross-term-0.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.